drugset / Trial / NCT00004079

Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00004079 ↗

Phase 1 Completed 46 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of sarcosinamide nitrosourea in treating patients who have metastatic or unresectable solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start
1999-08
Primary completion
2005-09
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject SarCNU Small molecule — Oral